insights_auto
Why is VRTX down 2.10%?
Dive Deeperchevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$523.93
arrow_downward
-2.10%(-11.24) 1D
$523.93
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$531.66
High
$533.08
Low
$522.91
Mkt. cap
132.80B
Avg. vol.
1.18M
Volume
832.63K
P/E ratio
30.48
52-wk high
$560.25
52-wk low
$403.16
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$531.66
High
$533.08
Low
$522.91
Mkt. cap
132.80B
Avg. vol.
1.18M
Volume
832.63K
P/E ratio
30.48
52-wk high
$560.25
52-wk low
$403.16
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
14 hours ago
Vertex Pharmaceuticals (VRTX) Posts Positive Phase 3 Results For Povetacicept
The Motley Fool
·
21 hours ago
Vertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change.
Yahoo Finance
·
2 days ago
Vertex Pharmaceuticals Incorpor (VRTX) Stock Forecasts
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com